122 related articles for article (PubMed ID: 34655352)
1. Access Denied: Inequities in Clinical Trial Enrollment for Pancreatic Cancer.
Eskander MF; Gil L; Beal EW; Li Y; Hamad A; Oppong B; Obeng-Gyasi S; Tsung A
Ann Surg Oncol; 2022 Feb; 29(2):1271-1277. PubMed ID: 34655352
[TBL] [Abstract][Full Text] [Related]
2. Disparities in phase 1 cancer clinical trial enrollment.
Perni S; Moy B; Nipp RD
Cancer; 2021 Dec; 127(23):4464-4469. PubMed ID: 34379799
[TBL] [Abstract][Full Text] [Related]
3. National enrollment of lung cancer clinical trials is disproportionate based on race and health care access.
Kwak M; Bassiri A; Jiang B; Sinopoli J; Tapias-Vargas L; Linden PA; Towe CW
J Thorac Cardiovasc Surg; 2023 Dec; ():. PubMed ID: 38123063
[TBL] [Abstract][Full Text] [Related]
4. Disparity in Clinical Trial Participation Among Patients with Gastrointestinal Cancer.
Abbas A; Diaz A; Obeng-Gyasi S; Cloyd JM; Ejaz A; Stewart JH; Pawlik TM
J Am Coll Surg; 2022 Apr; 234(4):589-598. PubMed ID: 35290279
[TBL] [Abstract][Full Text] [Related]
5. Disparities in clinical trial participation in ovarian cancer: A real-world analysis.
Smith AJB; Alvarez R; Heintz J; Simpkins F; Ko EM
Gynecol Oncol; 2023 Aug; 175():25-31. PubMed ID: 37300995
[TBL] [Abstract][Full Text] [Related]
6. Associations between Medicaid enrollment and diagnosis stage and survival among pediatric cancer patients.
Johnson KJ; Brown DS; O'Connell CP; Thompson T; Barnes JM; King AA
Pediatr Blood Cancer; 2024 May; 71(5):e30861. PubMed ID: 38235939
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K
Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138
[TBL] [Abstract][Full Text] [Related]
8. A nationwide analysis of pancreatic cancer trial enrollment reveals disparities and participation problems.
Hue JJ; Katayama ES; Markt SC; Elshami M; Saltzman J; Bajor D; Hosmer A; Mok S; Dumot J; Ammori JB; Rothermel LD; Hardacre JM; Winter JM; Ocuin LM
Surgery; 2022 Jul; 172(1):257-264. PubMed ID: 34839935
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment?
Jimenez R; Zhang B; Joffe S; Nilsson M; Rivera L; Mutchler J; Lathan C; Paulk ME; Prigerson HG
J Palliat Med; 2013 Mar; 16(3):256-62. PubMed ID: 23384245
[TBL] [Abstract][Full Text] [Related]
10. Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.
Patel MA; Shah JL; Brinley FJ; Abrahamse PH; Veenstra CM; Schott AF
Cancer Med; 2023 Jun; 12(11):12802-12812. PubMed ID: 37151163
[TBL] [Abstract][Full Text] [Related]
11. Association of social determinants of health with late diagnosis and survival of patients with pancreatic cancer.
Fabregas JC; Riley KE; Brant JM; George TJ; Orav EJ; Lam MB
J Gastrointest Oncol; 2022 Jun; 13(3):1204-1214. PubMed ID: 35837201
[TBL] [Abstract][Full Text] [Related]
12. The impact of insurance on access to cancer clinical trials at a comprehensive cancer center.
Klamerus JF; Bruinooge SS; Ye X; Klamerus ML; Damron D; Lansey D; Lowery JC; Diaz LA; Ford JG; Kanarek N; Rudin CM
Clin Cancer Res; 2010 Dec; 16(24):5997-6003. PubMed ID: 21169253
[TBL] [Abstract][Full Text] [Related]
13. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
[TBL] [Abstract][Full Text] [Related]
14. Improved access and quality of care after enrollment in the New York State Children's Health Insurance Program (SCHIP).
Szilagyi PG; Dick AW; Klein JD; Shone LP; Zwanziger J; McInerny T
Pediatrics; 2004 May; 113(5):e395-404. PubMed ID: 15121980
[TBL] [Abstract][Full Text] [Related]
15. California Medicaid enrollment and melanoma stage at diagnosis: a population-based study.
Pollitt RA; Clarke CA; Shema SJ; Swetter SM
Am J Prev Med; 2008 Jul; 35(1):7-13. PubMed ID: 18482824
[TBL] [Abstract][Full Text] [Related]
16. Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.
Riner AN; Girma S; Vudatha V; Mukhopadhyay N; Skoro N; Gal TS; Freudenberger DC; Herremans KM; George TJ; Trevino JG
J Clin Oncol; 2022 Jul; 40(20):2193-2202. PubMed ID: 35316089
[TBL] [Abstract][Full Text] [Related]
17. A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollment.
Elshami M; Hue JJ; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Chavin KD; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
HPB (Oxford); 2022 Aug; 24(8):1280-1290. PubMed ID: 35063353
[TBL] [Abstract][Full Text] [Related]
18. Socioeconomic Factors Associated With a Late-Stage Pancreatic Cancer Diagnosis: An Analysis of the National Cancer Database.
Gallegos JM; Taylor A; Vardell V; Silberstein PT
Cureus; 2023 Mar; 15(3):e35857. PubMed ID: 37033563
[TBL] [Abstract][Full Text] [Related]
19. Impact of Medicaid Expansion Status and Race on Metastatic Disease at Diagnosis in Patients with Melanoma.
Fabregas JC; Carter BT; Lutzky J; Robinson WR; Brant JM
J Racial Ethn Health Disparities; 2022 Dec; 9(6):2291-2299. PubMed ID: 34648145
[TBL] [Abstract][Full Text] [Related]
20. Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity.
Swords DS; Mulvihill SJ; Brooke BS; Skarda DE; Firpo MA; Scaife CL
Surgery; 2019 Apr; 165(4):751-759. PubMed ID: 30551868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
